The Bulletin
Men's Weekly


.

Harbour BioMed Announces License Agreement with Windward Bio for HBM9378/SKB378, an Anti-TSLP Fully Human Antibody for Immunological Diseases

  • Written by PR Newswire
Harbour BioMed Announces License Agreement with Windward Bio for HBM9378/SKB378, an Anti-TSLP Fully Human Antibody for Immunological Diseases

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Jan. 10, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immune-oncology and immunology, today announced that the Company and...

The Bulletin Magazine

eCommerce Site Design: Building Modern, High-Performing Online Stores for Australian Businesses

Your Reliable Partner for Every Roadside Emergency

Choosing Waterproofing Membranes for Outdoor Spaces: The Essential Attributes You Need

How Modular Content Accelerates Turnaround for Time-Sensitive Campaigns

How Litigation Lawyers in Sydney Can Help Resolve Disputes Efficiently

Revitalising Homes and Offices with Professional Carpet Cleaning Melbourne

Gum Grafting for Receding Gums: Cost, Recovery Time, and What to Expect

Why It’s Convenient to Buy Ceiling Fans Online

Creating Functional and Welcoming Spaces with a Professional Medical Clinic Fitout

10 Thoughtful Gift Ideas That Show You Truly Care

Debt Collection vs. Debt Recovery: What’s the Difference?

CHEAPER RIDES FOR FANS AS 13CABS CUTS FARES FOR FINALS WEEK